Craig Bijou
Stock Analyst at B of A Securities
(3.85)
# 451
Out of 4,829 analysts
62
Total ratings
64.71%
Success rate
61.33%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $53.11 | +58.16% | 4 | Apr 25, 2025 | |
RXST RxSight | Maintains: Buy | $60 → $36 | $13.06 | +175.65% | 1 | Mar 21, 2025 | |
TFX Teleflex | Downgrades: Underperform | $235 → $140 | $125.11 | +11.90% | 5 | Mar 4, 2025 | |
BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $11.27 | +50.84% | 3 | Feb 20, 2025 | |
GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $55.82 | +73.77% | 4 | Jan 9, 2025 | |
IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $12.25 | +46.94% | 13 | Oct 7, 2024 | |
ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $118.44 | +22.42% | 3 | Oct 1, 2024 | |
MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $95.83 | +7.48% | 3 | Sep 16, 2024 | |
HAE Haemonetics | Initiates: Neutral | $85 | $68.19 | +24.65% | 1 | Sep 11, 2024 | |
GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $69.87 | +23.09% | 2 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $82.26 | +15.49% | 1 | Oct 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.49 | +94.70% | 2 | Jan 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $5.98 | +653.14% | 3 | May 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.43 | +1,773.98% | 2 | Mar 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.65 | +545.16% | 5 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $8.71 | +49.25% | 2 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $12.11 | +246.82% | 3 | Feb 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $536.51 | -57.13% | 1 | Jan 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $380.92 | -39.62% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $53.11
Upside: +58.16%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60 → $36
Current: $13.06
Upside: +175.65%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $125.11
Upside: +11.90%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $11.27
Upside: +50.84%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $55.82
Upside: +73.77%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $12.25
Upside: +46.94%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $118.44
Upside: +22.42%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $95.83
Upside: +7.48%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $68.19
Upside: +24.65%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $69.87
Upside: +23.09%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $82.26
Upside: +15.49%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.49
Upside: +94.70%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $5.98
Upside: +653.14%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.43
Upside: +1,773.98%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.65
Upside: +545.16%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $8.71
Upside: +49.25%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $12.11
Upside: +246.82%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $536.51
Upside: -57.13%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $380.92
Upside: -39.62%